Download
00406_2023_Article_1652.pdf 684,38KB
WeightNameValue
1000 Titel
  • Treatment of adult attention-deficit hyperactivity disorder (ADHD) with transcranial direct current stimulation (tDCS): study protocol for a parallel, randomized, double-blinded, sham-controlled, multicenter trial (Stim-ADHD)
1000 Autor/in
  1. Mauche, Nicole |
  2. Ulke, Christine |
  3. Huang, Jue |
  4. Franke, Annegret |
  5. Bogatsch, Holger |
  6. Ethofer, Thomas |
  7. Grimm, Oliver |
  8. Frodl, Thomas |
  9. Hoffmann, Knut |
  10. Juckel, Georg |
  11. Kittel-Schneider, Sarah |
  12. Mehren, Aylin |
  13. Philipsen, Alexandra |
  14. Plewnia, Christian |
  15. Reif, Andreas |
  16. Ziegler, Georg C. |
  17. Strauss, Maria |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2023
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2023-07-22
1000 Erschienen in
1000 Quellenangabe
  • 274(1):71-82
1000 Copyrightjahr
  • 2023
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00406-023-01652-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10786982/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation treatment used as an alternative or complementary treatment for various neuropsychiatric disorders, and could be an alternative or add-on therapy to psychostimulants in attention-deficit hyperactivity disorder (ADHD). Previous studies provided some evidence for improvements in cognition and clinical symptoms in pediatric and adult ADHD patients. However, data from multi-center randomized controlled trials (RCTs) for this condition are lacking. Thus, our aim is to evaluate short- and mid-term effects of tDCS in this multi-center, randomized, double blind, and sham-controlled, parallel group clinical trial with a 1:1 randomization ratio. Primary endpoint is the total score of DSM-IV scale of the internationally established Conners’ Adult ADHD Rating Scales (German self-report screening version, CAARS-S-SR), at day 14 post-intervention (p.i.) to detect short-term lasting effects analyzed via analyses of covariance (ANCOVAs). In case of significant between-groups differences at day 14 p.i., hierarchically ordered hypotheses on mid-term lasting effects will be investigated by linear mixed models with visit (5 time points), treatment, treatment by visit interaction, and covariates as fixed categorical effects plus a patient-specific visit random effect, using an unstructured covariance structure to model the residual within-patient errors. Positive results of this clinical trial will expand the treatment options for adult ADHD patients with tDCS and provide an alternative or add-on therapy to psychostimulants with a low risk for side effects.</jats:p><jats:p><jats:italic>Trial Registration</jats:italic> The trial was registered on July 29, 2022 in the German Clinical Trials Register (DRKS00028148).</jats:p>
1000 Sacherschließung
lokal Attention Deficit Disorder with Hyperactivity/diagnosis [MeSH]
lokal Double-Blind Method [MeSH]
lokal Randomized
lokal Adult [MeSH]
lokal Multicenter
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Adult ADHD
lokal Multicenter Studies as Topic [MeSH]
lokal Transcranial Direct Current Stimulation/methods [MeSH]
lokal Sham-controlled trial
lokal Brain stimulation
lokal Randomized Controlled Trials as Topic [MeSH]
lokal Transcranial direct current stimulation
lokal Original Paper
lokal Cognition [MeSH]
lokal Central Nervous System Stimulants/therapeutic use [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TWF1Y2hlLCBOaWNvbGU=|https://frl.publisso.de/adhoc/uri/VWxrZSwgQ2hyaXN0aW5l|https://frl.publisso.de/adhoc/uri/SHVhbmcsIEp1ZQ==|https://frl.publisso.de/adhoc/uri/RnJhbmtlLCBBbm5lZ3JldA==|https://frl.publisso.de/adhoc/uri/Qm9nYXRzY2gsIEhvbGdlcg==|https://frl.publisso.de/adhoc/uri/RXRob2ZlciwgVGhvbWFz|https://frl.publisso.de/adhoc/uri/R3JpbW0sIE9saXZlcg==|https://frl.publisso.de/adhoc/uri/RnJvZGwsIFRob21hcw==|https://frl.publisso.de/adhoc/uri/SG9mZm1hbm4sIEtudXQ=|https://frl.publisso.de/adhoc/uri/SnVja2VsLCBHZW9yZw==|https://frl.publisso.de/adhoc/uri/S2l0dGVsLVNjaG5laWRlciwgU2FyYWg=|https://frl.publisso.de/adhoc/uri/TWVocmVuLCBBeWxpbg==|https://frl.publisso.de/adhoc/uri/UGhpbGlwc2VuLCBBbGV4YW5kcmE=|https://frl.publisso.de/adhoc/uri/UGxld25pYSwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/UmVpZiwgQW5kcmVhcw==|https://frl.publisso.de/adhoc/uri/WmllZ2xlciwgR2VvcmcgQy4=|https://orcid.org/0000-0002-0072-2199
1000 Hinweis
  • DeepGreen-ID: 3891877ae26745a9905decbb4ae97dff ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ;
1000 Label
1000 Förderer
  1. Deutsche Forschungsgemeinschaft |
  2. Universitätsklinikum Leipzig |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Deutsche Forschungsgemeinschaft |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Leipzig |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6521103.rdf
1000 Erstellt am 2025-07-06T05:33:02.806+0200
1000 Erstellt von 322
1000 beschreibt frl:6521103
1000 Zuletzt bearbeitet 2025-08-04T09:54:02.799+0200
1000 Objekt bearb. Mon Aug 04 09:54:02 CEST 2025
1000 Vgl. frl:6521103
1000 Oai Id
  1. oai:frl.publisso.de:frl:6521103 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source